Treatment of Early-Stage Gynecological Cancer-Related Lower Limb Lymphedema by Lymphaticovenular Anastomosis-The Triple Incision Approach.
cervical cancer
endometrial cancer
gynecological cancer
lymphaticovenular anastomosis
lymphedema
lymphedema treatment
pelvic lymphadenectomy
personalized medicine
quality of life
supermicrosurgery
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
01 May 2022
01 May 2022
Historique:
received:
03
04
2022
revised:
23
04
2022
accepted:
26
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
1
6
2022
Statut:
epublish
Résumé
Background and Objectives: Lower extremity lymphedema (LEL) is one of the most relevant chronic and disabling sequelae after gynecological cancer therapy involving pelvic lymphadenectomy (PL). Supermicrosurgical lymphaticovenular anastomosis (LVA) is a safe and effective procedure to treat LEL, particularly indicated in early-stage cases when conservative therapies are insufficient to control the swelling. Usually, preoperative assessment of these patients shows patent and peristaltic lymphatic vessels that can be mapped throughout the limb to plan the sites of skin incision to perform LVA. The aim of this study is to report the efficacy of our approach based on planning LVA in three areas of the lower limb in improving early-stage gynecological cancer-related lymphedema (GCRL) secondary to PL. Materials and Methods: We retrospectively reviewed the data of patients who underwent LVA for the treatment of early-stage GCRL following PL. Patients who had undergone groin dissection were excluded. Our preoperative study based on indocyanine green lymphography (ICG-L) and color doppler ultrasound (CDU) planned three incision sites located in the groin, in the medial surface of the distal third of the thigh, and in the upper half of the leg, to perform LVA. The primary outcome measure was the variation of the mean circumference of the limb after surgery. The changes between preoperative and postoperative limbs’ measures were analyzed by Student’s t-test. p values < 0.05 were considered significant. Results: Thirty-three patients were included. In every patient, three incision sites were employed to perform LVA. A total of 119 LVA were established, with an average of 3.6 for each patient. The mean circumference of the operated limb showed a significant reduction after surgery, decreasing from 37 cm ± 4.1 cm to 36.1 cm ± 4.4 (p < 0.01). Conclusions: Our results suggest that in patients affected by early-stage GCRL secondary to PL, the placement of incision sites in all the anatomical subunits of the lower limb is one of the key factors in achieving good results after LVA.
Identifiants
pubmed: 35630048
pii: medicina58050631
doi: 10.3390/medicina58050631
pmc: PMC9143574
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Cancer Invest. 2015 Mar;33(2):34-8
pubmed: 25608635
Ann Plast Surg. 2006 Sep;57(3):300-4
pubmed: 16929199
Microsurgery. 2019 Oct;39(7):605-612
pubmed: 31400162
J Surg Oncol. 2020 Jan;121(1):129-137
pubmed: 31246288
Ann Plast Surg. 2013 Feb;70(2):144-8
pubmed: 22868299
Plast Reconstr Surg. 2011 May;127(5):1979-1986
pubmed: 21532424
Microsurgery. 2020 Feb;40(2):130-136
pubmed: 31489971
J Surg Oncol. 2020 Jan;121(1):175-181
pubmed: 31165487
PLoS One. 2012;7(6):e38182
pubmed: 22675520
Plast Reconstr Surg Glob Open. 2018 Feb 26;6(2):e1679
pubmed: 29616175
Clin Exp Metastasis. 2018 Aug;35(5-6):553-558
pubmed: 29980891
Aesthetic Plast Surg. 2012 Feb;36(1):213-4
pubmed: 21656061
Aesthetic Plast Surg. 2012 Oct;36(5):1179-85
pubmed: 22936375
Ann Plast Surg. 2022 May 1;88(5):524-532
pubmed: 34670962
Ann Plast Surg. 2013 Nov;71(5):591-4
pubmed: 24126343
J Surg Oncol. 2018 Feb;117(2):290-298
pubmed: 29058780
J Surg Res. 2022 Jan;269:103-109
pubmed: 34547586
Ann Plast Surg. 2004 Sep;53(3):261-6
pubmed: 15480014
J Plast Reconstr Aesthet Surg. 2022 Mar;75(3):1150-1157
pubmed: 34866009
J Reconstr Microsurg. 2016 Jan;32(1):42-9
pubmed: 26029991
Aesthetic Plast Surg. 2013 Jun;37(3):640-2
pubmed: 23494028
J Plast Reconstr Aesthet Surg. 2018 Sep;71(9):1274-1281
pubmed: 30173714
Radiol Med. 2017 Dec;122(12):918-927
pubmed: 28770484
J Plast Reconstr Aesthet Surg. 2012 Nov;65(11):1551-8
pubmed: 22817883
Microsurgery. 2016 Jul;36(5):397-401
pubmed: 25854520
Ann Plast Surg. 2016 Apr;76(4):424-7
pubmed: 25389716
Cancers (Basel). 2021 Nov 17;13(22):
pubmed: 34830901
Ann Vasc Surg. 2017 Oct;44:442-450
pubmed: 28483624
Lymphology. 2020;53(1):3-19
pubmed: 32521126
Clin Chim Acta. 2005 Dec;362(1-2):85-93
pubmed: 16054123
PLoS One. 2012;7(7):e41126
pubmed: 22911751
J Vasc Surg. 2012 Mar;55(3):753-60
pubmed: 22209609
Microsurgery. 2021 Sep;41(6):574-578
pubmed: 33991012
Medicina (Kaunas). 2021 Oct 28;57(11):
pubmed: 34833393
Microsurgery. 2016 May;36(4):310-5
pubmed: 26666982
Ann Plast Surg. 2014 Jan;72(1):67-70
pubmed: 23241778
Plast Reconstr Surg. 2019 Aug;144(2):486-496
pubmed: 31348365
Plast Reconstr Surg. 2014 Apr;133(4):887-896
pubmed: 24675191
Br J Surg. 2014 Oct;101(11):1391-6
pubmed: 25116167
Microsurgery. 2017 Sep;37(6):564-573
pubmed: 27987230
Gynecol Oncol. 2015 Oct;139(1):160-4
pubmed: 26186910
Plast Reconstr Surg. 2013 Feb;131(2):283-290
pubmed: 23357989
Aesthetic Plast Surg. 2012 Feb;36(1):23-7
pubmed: 21695578
Curr Pharm Des. 2019;25(22):2480-2490
pubmed: 31333115
Cancers (Basel). 2022 Feb 21;14(4):
pubmed: 35205824
J Vasc Surg. 2007 May;45(5):1016-21
pubmed: 17391894
J Reconstr Microsurg. 2000 Aug;16(6):437-42
pubmed: 10993089
Microsurgery. 2017 Nov;37(8):881-889
pubmed: 28952193
J Clin Med. 2022 Jan 24;11(3):
pubmed: 35160022